Torsades de Pointes ventricular tachycardia in a pediatric patient treated with fluconazole

被引:16
作者
Esch, Jesse J. [1 ]
Kantoch, Michal J. [1 ]
机构
[1] Stollery Childrens Hosp, Dept Pediat, Edmonton, AB T6G 2R7, Canada
关键词
fluconazole; Torsades de Pointes; QT interval; Long QT syndrome;
D O I
10.1007/s00246-007-9076-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fluconazole is an antifungal medication that has been reported to cause prolongation of the QT interval and Torsades de Pointes (TdP) ventricular tachycardia in adults. We describe the case of an 11-year-old child treated with Fluconazole who developed ventricular arrhythmia culminating in TdP. We discuss the possible roles played by genetic and environmental factors in this child's rhythm disturbances. After briefly summarizing similar cases from the adult literature, we outline the putative mechanism by which Fluconazole may cause arrhythmia. This case should alert pediatricians to the possible risks of Fluconazole use, especially in the presence of electrolyte abnormalities, diuretic use, therapy with other pro-arrhythmic agents, or suspicion of congenital Long-QT Syndrome.
引用
收藏
页码:210 / 213
页数:4
相关论文
共 12 条
  • [1] Prolonged QT interval and torsades de pointes caused by the combination of fluconazole and amitriptyline
    Dorsey, ST
    Biblo, LA
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2000, 18 (02) : 227 - 229
  • [2] Fluconazole- and levofloxacin-induced torsades de pointes in an intensive care unit patient
    Gandhi, PJ
    Menezes, PA
    Vu, MT
    Rivera, AL
    Ramaswamy, K
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (23) : 2479 - 2483
  • [3] Probable case of Torsades de Pointes induced by fluconazole
    Khazan, M
    Mathis, AS
    [J]. PHARMACOTHERAPY, 2002, 22 (12): : 1632 - 1637
  • [4] Blockade of HERG cardiac K+ current by antifungal drug miconazole
    Kikuchi, K
    Nagatomo, T
    Abe, H
    Kawakami, K
    Duff, HJ
    Makielski, JC
    January, CT
    Nakashima, Y
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2005, 144 (06) : 840 - 848
  • [5] Libersa CC, 2000, BRIT J CLIN PHARMACO, V49, P373
  • [6] Low penetrance in the long-QT syndrome - Clinical impact
    Priori, SG
    Napolitano, C
    Schwartz, PJ
    [J]. CIRCULATION, 1999, 99 (04) : 529 - 533
  • [7] Inhibition of the HERG K+ channel by the antifungal drug ketoconazole depends on channel gating and involves the S6 residue F656
    Ridley, JM
    Milnes, JT
    Duncan, RS
    McPate, MJ
    James, AF
    Witchel, HJ
    Hancox, JC
    [J]. FEBS LETTERS, 2006, 580 (08): : 1999 - 2005
  • [8] Spectrum of mutations in long-QT syndrome genes KVLQT1, HERG, SCN5A, KCNE1, and KCNE2
    Splawski, I
    Shen, JX
    Timothy, KW
    Lehmann, MH
    Priori, S
    Robinson, JL
    Moss, AJ
    Schwartz, PJ
    Towbin, JA
    Vincent, GM
    Keating, MT
    [J]. CIRCULATION, 2000, 102 (10) : 1178 - 1185
  • [9] Torsades de pointes upon fluconazole administration in a patient with acute myeloblastic leukemia
    Tatetsu, Hiro
    Asou, Norio
    Nakamura, Mik
    Hanaoka, Nobuyoshi
    Matsuno, Fumihiko
    Horikawa, Kentaro
    Mitsuya, Hiroaki
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (05) : 366 - 369
  • [10] Tholakanahalli VN, 2001, ANN PHARMACOTHER, V35, P432, DOI 10.1345/aph.10210